China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Set to Reverse Split on Tuesday, February 25th

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCFree Report) shares are going to reverse split before the market opens on Tuesday, February 25th. The 1-8 reverse split was announced on Friday, February 21st. The number of shares owned by shareholders will be adjusted after the market closes on Monday, February 24th.

China SXT Pharmaceuticals Trading Down 8.7 %

NASDAQ SXTC traded down $0.03 during mid-day trading on Friday, hitting $0.34. The company’s stock had a trading volume of 1,544,507 shares, compared to its average volume of 439,662. China SXT Pharmaceuticals has a 52-week low of $0.30 and a 52-week high of $3.37. The stock’s fifty day simple moving average is $0.41 and its two-hundred day simple moving average is $0.55.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Featured Articles

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.